Hjem › Alvorlig depressiv lidelse › Virginia
Alvorlig depressiv lidelse kliniske forsøg i Virginia
7 studier for Alvorlig depressiv lidelse søger deltagere på steder i Virginia.
Byer i Virginia
Officiel studietekst (engelsk)
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Richmond
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07105111Evaluating Conversational Artificial Intelligence for Depression Management
- George Mason University, Fairfax
Rekrutterer
Alder 18 til 85 · Alle køn · Opdateret 9. sep. 2026 · NCT07105397NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Charlottesville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT06911112A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Re:Cognition Health, Fairfax
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 6. aug. 2026 · NCT07412756A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Roanoke
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT07196501Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #145, Fairfax
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 20. jan. 2026 · NCT06633016Study of ALTO-300 in MDD
- Site 211, Roanoke
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 24. jul. 2025 · NCT05922878Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.